Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care
A Tsakris1, A Ikonomidis, A Poulou
1Department of Microbiology, Medical School, University of Athens, Athens, Greece. atsakris@med.uoa.gr
Abstract:
During a 2-year period (April 2005-March 2007), 31 intensive care unit (ICU) patients in a Greek hospital were infected or colonised with imipenem-resistant isolates of Acinetobacter baumannii. Twelve patients died, with imipenem-resistant A. baumannii infection contributing to the death of seven patients. The 31 representative A. baumannii isolates were multidrug-resistant and clustered in four distinct clones, each of which contained different carbapenemase genes: clone I was predominant and contained bla(VIM-1), bla(OXA-58) and the intrinsic bla(OXA-66) gene; clone II contained bla(VIM-4), bla(OXA-58) and the intrinsic bla(OXA-69) gene; clone III contained bla(OXA-58) and the intrinsic bla(OXA-69) gene; and clone IV contained only the intrinsic bla(OXA-66) gene. ISAba1 was not associated with the intrinsic bla(OXA-51-like) alleles, whereas ISAba3 was found upstream and downstream of bla(OXA-58) in isolates of clone I, and upstream of bla(OXA-58) in isolates of clone III, but was not detected in isolates of clone II. PCR, curing and hybridisation experiments indicated that the bla(VIM) alleles were chromosomally located, whereas the bla(OXA-58) alleles were plasmid-located. This study provides the first description of the clonal spread of multidrug-resistant A. baumannii isolates carrying bla(VIM-1) and bla(VIM-4) metallo-beta-lactamase genes, and revealed that distinct carbapenem-resistant A. baumannii clusters bearing different carbapenemase genes may emerge and cause severe infections, even in a well-defined regional hospital setting.
Insights
Multidrug-resistant Acinetobacter baumannii strains carrying carbapenemase genes caused severe infections in a Greek hospital. This study highlights the clonal spread of these resistant bacteria and their impact on patient mortality.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Genetics
Background:
- Acinetobacter baumannii is a significant cause of hospital-acquired infections, particularly in intensive care units (ICUs).
- The emergence of carbapenem resistance in A. baumannii poses a major threat to patient treatment and outcomes.
- Understanding the genetic basis and clonal dissemination of resistant strains is crucial for infection control.
Purpose of the Study:
- To investigate the characteristics of imipenem-resistant Acinetobacter baumannii isolates from ICU patients in a Greek hospital.
- To identify the carbapenemase genes and clonal types involved in infections and colonizations.
- To determine the genetic location and spread of resistance determinants.
Main Methods:
- Surveillance of ICU patients over a 2-year period for imipenem-resistant A. baumannii.
- Molecular typing to identify distinct clones.
- Detection and characterization of carbapenemase genes (blaVIM, blaOXA) using PCR, curing, and hybridization.
- Analysis of insertion sequences (ISAba1, ISAba3) associated with resistance genes.
Main Results:
- Thirty-one imipenem-resistant A. baumannii isolates were identified, with 7 patient deaths attributed to infection.
- Isolates belonged to four distinct multidrug-resistant clones.
- Different carbapenemase genes (blaVIM-1, blaVIM-4, blaOXA-58) were found in different clones.
- blaVIM genes were chromosomally located, while blaOXA-58 genes were plasmid-located.
Conclusions:
- This study is the first to describe the clonal spread of multidrug-resistant A. baumannii carrying blaVIM-1 and blaVIM-4.
- Distinct carbapenem-resistant A. baumannii clones with varying carbapenemase genes can emerge and cause severe infections.
- Effective infection control strategies are essential to manage the spread of carbapenem-resistant A. baumannii in healthcare settings.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
